Skip to main content
SpringerLink
Log in

Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease

  • Chapter
  • First Online:
Pediatric Inflammatory Bowel Disease

  • 680 Accesses

Abstract

Inflammatory bowel disease (IBD) is a multi-system disease and appropriate patient care has to factor in associated extraintestinal manifestations (EIMs) which can affect almost all other organ systems. These EIMs can occur at disease onset and be the only presenting symptom or they may appear after diagnosis and substantially impact the quality of life. This chapter will describe the more common extraintestinal manifestations in pediatric patients with IBD.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Oliva-Hemker M. More than a gut reaction: Extraintestinal complications of IBD. Contemp Pediatr. 1999;16:45.

    Google Scholar 

  2. Vavricka SR, Brun L, Ballabeni P, Pittet V, Vavricka BMP, Zeitz J, Rogler G, Schoepfer AM. Swiss IBD Cohort Study Group. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol. 2011;106:110–9.

    PubMed  Google Scholar 

  3. Jose FA, Garnett EA, Vittinghoff E, Ferry GD, Winter HS, Baldassano RN, Kirschner BS, Cohen SA, Gold BD, Abramson O, Heyman MB. Development of extraintestinal manifestations in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis. 2009;15:63–8.

    PubMed  Google Scholar 

  4. Dotson JL, Hyams JS, Markowitz J, LeLeiko NS, Mack DR, Evans JS, Pfefferkorn MD, Griffiths AM, Otley AR, Bousvaros A, Kugathasan S, Rosh JR, Keljo D, Carvalho RS, Tomer G, Mamula P, Kay MH, Kerzner B, Oliva-Hemker M, Langton CR, Crandall W. Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to disease type and severity. JPGN. 2010;51:140–5.

    PubMed  Google Scholar 

  5. Greuter T, Bertoldo F, Rechner R, et al. Extraintestinal manifestations of pediatric inflammatory bowel disease: prevalence, presentation, and anti-tnf treatment. JPGN. 2017;65:200–26.

    CAS  PubMed  Google Scholar 

  6. Jansson S, Malham M, Paerregaard A, Jakobsen C, Wewer V. Extraintestinal manifestations are associated with disease severity in pediatric onset inflammatory bowel disease. JPGN. 2020;71:40–5.

    CAS  PubMed  Google Scholar 

  7. Duricova D, Sarter H, Savoye G, et al. Impact of extra-intestinal manifestations at diagnosis on disease outcome in pediatric and elderly-onset Crohn’s disease: a French population-based study. Inflamm Bowel Dis. 2019;25:394–402.

    PubMed  Google Scholar 

  8. Cohen S, Padilpsky J, Yerushalmy-Feler A. Risk factors associated with extranintestinal manifestations in children with inflammatory bowel disease. Eur J Clin Nutr. 2020;74:691–7.

    CAS  PubMed  Google Scholar 

  9. Lichtman SN, Sartor RB. Extraintestinal manifestations of inflammatory bowel disease: clinical aspects and natural history. In: Targan S, Shanahan F, editors. Inflammatory bowel disease: from bench to bedside. Baltimore, MD: Williams and Wilkins; 1994.

    Google Scholar 

  10. Levine JB, Lukawski-Trubish D. Extraintestinal considerations in inflammatory bowel disease. Gastroenterol Clin North Am. 1995;24:633.

    CAS  PubMed  Google Scholar 

  11. Bhagat S, Das KM. A shared and unique peptide in the human colon, eye, and joint detected by a monoclonal antibody. Gastroenterology. 1994;107:103.

    CAS  PubMed  Google Scholar 

  12. Rothfuss KS, Stange EF, Herrlinger KR. Extraintestinal manifestations and complications in inflammatory bowel disease. World J Gastroenterol. 2006;12:4819.

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Adams DH, Eksteen B. Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease. Nat Rev Immunol. 2006;6:244.

    CAS  PubMed  Google Scholar 

  14. Lofberg R, Louis EV, Reinish W, Robinson AM, Kron M, Camez A, Pollack PF. Adalimumab produces clinical remission and reduces extraintestinal manifestations in Crohn disease: results from CARE. Inflamm Bowel Dis. 2012;18:1–9.

    PubMed  Google Scholar 

  15. Danese S, Semeraro S, Papa A, Roberto I, Scaldaferri F, Fedeli G, Gasbarrini G, Gasbarrini A. Extraintestinal manifestations in inflammatory bowel disease. World J Gastroenterol. 2005;11:7227.

    PubMed  PubMed Central  Google Scholar 

  16. Hyams JS. Extraintestinal manifestations of inflammatory bowel disease in children. J Pediatr Gastroenterol Nutr. 1994;19:7.

    CAS  PubMed  Google Scholar 

  17. Kethu SR. Extraintestinal manifestations of inflammatory bowel disease. J Clin Gastroenterol. 2006;40:467.

    PubMed  Google Scholar 

  18. Urlep D, Mamula P, Baldassano R. Extraintestinal manifestations of inflammatory bowel disease. Minerva Gastroenterol Dietol. 2005;51:147.

    CAS  PubMed  Google Scholar 

  19. Loftus EV. Management of extraintestinal manifestations and other complications of inflammatory bowel disease. Curr Gastroenterol Rep. 2004;6:506.

    PubMed  Google Scholar 

  20. Hoffmann RM, Kruis W. Rare extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis. 2004;10:140.

    CAS  PubMed  Google Scholar 

  21. Su CG, Judge TA, Lichtenstein GR. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Clin North Am. 2002;31:307.

    PubMed  Google Scholar 

  22. Jose FA, Heyman MB. Extraintestinal manifestations of inflammatory bowel disease. JPGN. 2008;46:124–33.

    PubMed  Google Scholar 

  23. Jang H, Kang B, Choe B. The difference in extraintestinal manifestations of inflammatory bowel disease in children and adults. Trans Pediatr. 2019;8:4–15.

    Google Scholar 

  24. Kanof ME, Lake AM, Bayles TM. Decreased height velocity in children and adolescents before the diagnosis of Crohn disease. Gastroenterology. 1988;95:1523.

    CAS  PubMed  Google Scholar 

  25. Conklin LS, Oliva-Hemker M. Nutritional considerations in pediatric inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2010;4:305–17.

    CAS  PubMed  Google Scholar 

  26. Passo MH, Fitzgerald JF, Brandt KD. Arthritis associated with inflammatory bowel disease in children—relationship of joint disease to activity and severity of bowel lesion. Dig Dis Sci. 1986;31:492.

    CAS  PubMed  Google Scholar 

  27. Horton DB, Sherry DD, Baldassano RN, Weiss PF. Enthesitis is an extraintestinal manifestation of pediatric inflammatory bowel disease. Ann Paediatr Rheumatol. 2012;1(4). https://doi.org/10.5455/apr.102920121510.

  28. Furman MS, Lee E. Beyond Crohn Disease: Current role of Radiologists in diagnostic imaging assessment of inflammatory bowel disease transitioning from pediatric to adult patients. Radiol Clin N Am. 2020;58:517–27.

    PubMed  Google Scholar 

  29. Garber A, Regueiro M. Extraintestinal manifestations of inflammatory bowel disease: epidemiology, etiopathogenesis, and management. Curr Gastro Rep. 2019;21:1–13.

    Google Scholar 

  30. Greuter T, Rieder F, Kucharzik T, et al. Emerging treatment options for extraintestinal manifestations in IBD. Gut. 2020;0:1–7.

    Google Scholar 

  31. Juillerat P, Mottet C, Froehlich F, Felley C, Vader J, Burnand B, Gonvers J, Michetti P. Extraintestinal manifestations of Crohn disease. Digestion. 2005;71:31–6.

    PubMed  Google Scholar 

  32. Fleisher M, Marsal J, Lee SD, et al. Effects of vedolizumab therapy on extraintestinal manifestations in inflammatory bowel disease. Dig Dis Sci. 2018;63:825–33.

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Lakatos PL, Altorjay I, Szamosi T, Palatka K, Vitalis Z, Tumpek J, Sipka S, Udvardy M, Dinya T, Lakatos L, Kovacs A, Molnar T, Tulassay Z, Miheller P, Barta Z, Stocker W, Papp J, Veres G, Papp M. Hungarian IBD Study Group. Pancreatic autoantibodies are associated with reactivity to microbial antibodies, penetrating disease behavior, perianal disease, and extraintestinal manifestations, but not with NOD2/CARD15 or TLR4 genotype in a Hungarian IBD cohort. Inflamm Bowel Dis. 2009;15:365–74.

    PubMed  Google Scholar 

  34. Bernstein CN. Osteoporosis and other complications of inflammatory bowel disease. Curr Opin Gastroenterol. 2002;18:428.

    PubMed  Google Scholar 

  35. Gokhale R, Favus MJ, Karrison T, et al. Bone mineral density assessment in children with inflammatory bowel disease. Gastroenterology. 1998;114:902.

    CAS  PubMed  Google Scholar 

  36. Hyams JS, Wyzga N, Kreutzer DL, et al. Alterations in bone metabolism in children with inflammatory bowel disease: an in vitro study. J Pediatr Gastroenterol Nutr. 1997;24:289.

    CAS  PubMed  Google Scholar 

  37. Bousvaros A, Marcon M, Treem W, Waters P, Issenman R, Couper R, Burnell R, Rosenberg A, Rabinovish E, Kirschner B. Chronic recurrent multifocal osteomyelitis associated with chronic inflammatory bowel disease in children. Dig Dis Sci. 1999;44:2500–7.

    CAS  PubMed  Google Scholar 

  38. Lauritano D, Boccalari E, Stasio D, et al. Prevalence of oral lesions and correlation with intestinal symptoms of inflammatory bowel disease: a systemic review. Diagnostics. 2019;9:77–93.

    PubMed  PubMed Central  Google Scholar 

  39. Muhvic-Urek M, Tomac-Stojmenovic M, Mijandrusic-Sincic B. Oral pathology in inflammatory bowel disease. World J Gastroenterol. 2016;25:5655–67.

    Google Scholar 

  40. Plauth M, Jenss H, Meyle J. Oral manifestations of Crohn disease. J Clin Gastroenterol. 1991;13:29.

    CAS  PubMed  Google Scholar 

  41. Grilich C, Bogenrieder T, Palitzsch KD, Scholmerich J, Lock G. Orofacial granulomatosis as initial manifestation of Crohn disease: a report of two cases. Eur J Gastroenterol Hepatol. 2002;13:873–6.

    Google Scholar 

  42. Storwick GS, Prihoda MB, Fulton RJ, et al. Pyodermatitis-pyostomatitis vegetans: a specific marker for inflammatory bowel disease. J Am Acad Dermatol. 1994;31:336.

    CAS  PubMed  Google Scholar 

  43. Lynde CB, Brue AJ, Rogers RS. Successful treatment of complex aphthous with colchicine and dapsone. Arch Dermatol. 2009;145:273–6.

    CAS  PubMed  Google Scholar 

  44. Schneider SL, Foster K, Patel D, Shwayder T. Cutanoues manifestations of metastatic Crohn’s disease. Pediatr Dermatol. 2018;35:566–74.

    PubMed  Google Scholar 

  45. Antonelli E, Bassotti G, Tramontana M, et al. Dermatological manifestation in inflammatory bowel disease. J Clin Med. 2021;10:364–80.

    Google Scholar 

  46. Kugathasan S, Miranda A, Nocton J, Drolet BA, Raasch C, Binion DG. Dermatologic manifestations of Crohn disease in children: response to infliximab. J Pediatr Gastroenterol Nutr. 2003;37:150–4.

    CAS  PubMed  Google Scholar 

  47. Meinhardt C, Buning J, Fellermann K, Lehnert H, Schmidt KJ. Cyclophosphamide therapy in Sweet’s syndrome complicating refractory Crohn disease – efficacy and mechanism of action. J Crohns Colitis. 2011;6:633–7.

    Google Scholar 

  48. Foo WC, Papalas JA, Robboy SJ, Selim MA. Vulvar manifestations of Crohn disease. Am J Dermatopathol. 2011;33:588–93.

    PubMed  Google Scholar 

  49. Ottaviano G, Salvatore S, Salvatoni A, et al. Ocular manifestations of pediatric inflammatory bowel disease: a systematic review and meta-analysis. J Crohn’s Colitis. 2018;12:870–9.

    Google Scholar 

  50. Troncoso LL, Biancardi AL, Moraes V, Zaltman C. Ophthalmic manifestations in patients with inflammatory bowel disease: a review. World J Gastroenterol. 2017;23:5836–48.

    PubMed  PubMed Central  Google Scholar 

  51. Hofley P, Roarty J, McGinnity G, et al. Asymptomatic uveitis in children with chronic inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 1993;17:397.

    CAS  PubMed  Google Scholar 

  52. Purnak T, Yuksel O. Overview of venous thrombosis in inflammatory bowel disease. Inflamm Bowel Dis. 2015;21:1195–203.

    PubMed  Google Scholar 

  53. SriRajaskanthan R, Winter M, Muller AF. Venous thrombosis in inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2005;17:697.

    CAS  PubMed  Google Scholar 

  54. Mader R, Segol O, Adawi M, Trougoboff P, Nussinson E. Arthritis or vasculitis as presenting symptoms of Crohn disease. Rheumatol Int. 2005;25:401–5.

    PubMed  Google Scholar 

  55. Cardile S, Randazzo A, Valenti S, Romano C. Pancreatic involvement in pediatric inflammatory bowel diseases. World J Pediatr. 2015;11(3):207–11.

    CAS  PubMed  Google Scholar 

  56. Barthet M, Hastier P, Bernard JP, et al. Chronic pancreatitis and inflammatory bowel disease: true or coincidental association? Am J Gastroenterol. 1999;94:2141–8.

    CAS  PubMed  Google Scholar 

  57. Martin-de-Carpi J, Moriczi M, Pujol-Muncunill G, Navas-Lopez VM. Pancreatic involvement in pediatric inflammatory bowel disease. Front Pediatr. 2017;5:218.

    PubMed  PubMed Central  Google Scholar 

  58. Lauritzen D, Andreassen BU, Henrik N, et al. Pediatric inflammatory bowel diseases: Should we be looking for kidney abnormalities? Inflamm Bowel Dis. 2018;24:2599–605.

    PubMed  Google Scholar 

  59. Mutalib M. Renal involvement in pediatric inflammatory bowel disease. Pediatr Nephrol. 2021;36:279–85.

    PubMed  Google Scholar 

  60. Kuzmic AC, Kolacek S, Brkljacic B, Juzjak N. Renal artery stenosis associated with Crohn disease. Pediatr Nephrol. 2001;16:371–3.

    CAS  PubMed  Google Scholar 

  61. Barfield E, Deshmukh F, Slighton E, et al. Pulmonary manifestations in adolescents with inflammatory bowel disease. Clin Pediatr. 2020;59:573–9.

    Google Scholar 

  62. Camus P, Piard F, Ashcroft T, et al. The lung in inflammatory bowel disease. Medicine. 1993;72:151.

    CAS  PubMed  Google Scholar 

  63. Al-Binali AM, Scott B, Al-Garni A, Montgomery M, Robertson M. Granulomatous pulmonary disease in a child: an unusual presentation of Crohn disease. Pediatr Pulmonol. 2003;36:76–80.

    PubMed  Google Scholar 

  64. Haralambou G, Teirstein AS, Gil J, Present D. Bronchiolitis obliterans in a patient with ulcerative colitis receiving mesalamine. Mount Sinai J Med. 2001;68:384–8.

    CAS  Google Scholar 

  65. Lossos A, River Y, Eliakim A, et al. Neurologic aspects of inflammatory bowel disease. Neurology. 1995;45:416.

    CAS  PubMed  Google Scholar 

  66. Zois CD, Katsanos KH, Kosmidou M, Tsianos EV. Neurologic manifestations in inflammatory bowel disease: current knowledge and novel insights. J Crohns Colitis. 2010;4:115–24.

    PubMed  Google Scholar 

  67. Yarur AJ, Deshpande AR, Pechman DM, Tamariz L, Abreu MT. Inflammatory bowel disease is associated with an increased incidence of cardiovascular events. Am J Gastroenterol. 2011;106:741–7.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pediatric Inflammatory Bowel Disease Program, Department of Pediatrics, Cedars-Sinai Medical Center, Los Angeles, CA, USA

    Shervin Rabizadeh

  2. Division of Pediatric Gastroenterology, Hepatology and Nutrition, The Johns Hopkins University School of Medicine, Baltimore, MD, USA

    Maria Oliva-Hemker

Authors
  1. Shervin Rabizadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maria Oliva-Hemker
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maria Oliva-Hemker .

Editor information

Editors and Affiliations

  1. Division of GI, Hepatology & Nutrition, Children’s Hospital of Philadelphia, Philadelphia, PA, USA

    Petar Mamula

  2. Division of GI, Hepatology & Nutrition, Children’s Hospital of Philadelphia, Philadelphia, PA, USA

    Judith R. Kelsen

  3. Division of GI, Hepatology & Nutrition, Children’s Hospital of Philadelphia, Philadelphia, PA, USA

    Andrew B. Grossman

  4. Division of GI, Hepatology & Nutrition, Children’s Hospital of Philadelphia, Philadelphia, PA, USA

    Robert N. Baldassano

  5. Division of Pediatric Gastroenterology, Prisma Health Children’s Hospital—Upstate, Greenville, SC, USA

    Jonathan E. Markowitz

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Rabizadeh, S., Oliva-Hemker, M. (2023). Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease. In: Mamula, P., Kelsen, J.R., Grossman, A.B., Baldassano, R.N., Markowitz, J.E. (eds) Pediatric Inflammatory Bowel Disease. Springer, Cham. https://doi.org/10.1007/978-3-031-14744-9_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-14744-9_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-14743-2

  • Online ISBN: 978-3-031-14744-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation